Contact
Please use this form to send email to PR contact of this press release:
Teleflex receives FDA 510(k) Clearance for Expanded Indications of the QuikClot Control+™ Hemostatic Device
TO:
Please use this form to send email to PR contact of this press release:
Teleflex receives FDA 510(k) Clearance for Expanded Indications of the QuikClot Control+™ Hemostatic Device
TO: